WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New DDDs

List of new DDDs decided at the latest meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the ATC codes should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the new DDDs will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list,

 

ATC codeATC level name (INN/generic name)DDDUnit Adm.routeDeadline for objection to temporary DDDs Implementation in ATC/DDD index if no objection is received
A02BX14rebamipide0.3gO01.02.20172018
A10BF03voglibose0.6mgO01.02.20172018
A16AX14migalastat61.5mgO01.02.20172018
B01AC26vorapaxar2.08mgO01.02.20172018
B01AC27selexipag1.8mgO01.02.20172018
B03AB09ferric proteinsuccinylate80mgO Fe3+01.02.20172018
C09CA10fimasartan60mgO01.02.20172018
J01DD52ceftazidime and beta-lactamase inhibitor 1)62)P01.02.20172018
L03AA17pegteograstim0.3mgP01.02.20172018
N04BX04opicapone50mgO01.02.20172018
N07XX11pitolisant18mgO01.02.20172018
R03DX08reslizumab7.5mgP01.02.20172018
R06AA09doxylamine25mgO01.02.20172018
1) previous level name, ceftazidime, combinations
2) refers to ceftazidime

Last updated: 2016-12-06